BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20586419)

  • 1. Protease-activatable organometal-Peptide bioconjugates with enhanced cytotoxicity on cancer cells.
    Splith K; Hu W; Schatzschneider U; Gust R; Ott I; Onambele LA; Prokop A; Neundorf I
    Bioconjug Chem; 2010 Jul; 21(7):1288-96. PubMed ID: 20586419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the metal complex-to-peptide linker on the synthesis and properties of bioactive CpMn(CO)3 peptide conjugates.
    Splith K; Neundorf I; Hu W; Peindy N'Dongo HW; Vasylyeva V; Merz K; Schatzschneider U
    Dalton Trans; 2010 Mar; 39(10):2536-45. PubMed ID: 20179846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the metal center and linker on the intracellular distribution and biological activity of organometal-peptide conjugates.
    Hu W; Splith K; Neundorf I; Merz K; Schatzschneider U
    J Biol Inorg Chem; 2012 Feb; 17(2):175-85. PubMed ID: 21898043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cymantrene conjugation modulates the intracellular distribution and induces high cytotoxicity of a cell-penetrating peptide.
    Neundorf I; Hoyer J; Splith K; Rennert R; Peindy N'dongo HW; Schatzschneider U
    Chem Commun (Camb); 2008 Nov; (43):5604-6. PubMed ID: 18997966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivering aminopyridine ligands into cancer cells through conjugation to the cell-penetrating peptide BP16.
    Soler M; González-Bártulos M; Figueras E; Massaguer A; Feliu L; Planas M; Ribas X; Costas M
    Org Biomol Chem; 2016 Apr; 14(17):4061-70. PubMed ID: 27055538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and cytotoxic activity of metallic complexes of lawsone.
    Oramas-Royo S; Torrejón C; Cuadrado I; Hernández-Molina R; Hortelano S; Estévez-Braun A; de Las Heras B
    Bioorg Med Chem; 2013 May; 21(9):2471-7. PubMed ID: 23545136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syntheses, characterization, interaction with DNA, cytotoxic and apoptosis of two novel complexes of Zn(II) and Mn(II) with 2-methyl-1H-4,5-imidazoledicarboxylic acid.
    Li LF; Wang H; Zhang J; Ma C; Li YY; Wang L; Liang SK; Jin HT; Liu SJ; Zhu MC; Gao EJ
    Eur J Med Chem; 2015 Mar; 92():295-301. PubMed ID: 25575313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced cellular uptake and cytotoxicity studies of organometallic bioconjugates of the NLS peptide in Hep G2 cells.
    Noor F; Kinscherf R; Bonaterra GA; Walczak S; Wölfl S; Metzler-Nolte N
    Chembiochem; 2009 Feb; 10(3):493-502. PubMed ID: 19115329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palladacycle (BPC) antitumour activity against resistant and metastatic cell lines: the relationship with cytosolic calcium mobilisation and cathepsin B activity.
    Bechara A; Barbosa CM; Paredes-Gamero EJ; Garcia DM; Silva LS; Matsuo AL; Nascimento FD; Rodrigues EG; Caires AC; Smaili SS; Bincoletto C
    Eur J Med Chem; 2014 May; 79():24-33. PubMed ID: 24709226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organometallic anticancer agents that interfere with cellular energy processes: a subtle approach to inducing cancer cell death.
    Nazarov AA; Gardini D; Baquié M; Juillerat-Jeanneret L; Serkova TP; Shevtsova EP; Scopelliti R; Dyson PJ
    Dalton Trans; 2013 Feb; 42(7):2347-50. PubMed ID: 23223548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of phenylene bridged binuclear bis(imino-quinolyl)palladium(II) and platinum(II) complexes.
    Motswainyana WM; Onani MO; Madiehe AM; Saibu M
    Bioorg Med Chem Lett; 2014 Apr; 24(7):1692-4. PubMed ID: 24636106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New titanocene derivatives with high antiproliferative activity against breast cancer cells.
    Saturnino C; Sirignano E; Botta A; Sinicropi MS; Caruso A; Pisano A; Lappano R; Maggiolini M; Longo P
    Bioorg Med Chem Lett; 2014 Jan; 24(1):136-40. PubMed ID: 24332626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide Bioconjugates of Electron-Poor Metallocenes: Synthesis, Characterization, and Anti-Proliferative Activity.
    Maschke M; Grohmann J; Nierhaus C; Lieb M; Metzler-Nolte N
    Chembiochem; 2015 Jun; 16(9):1333-42. PubMed ID: 26012853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of Mn(III) complexes in combination with phototherapy and antioxidant therapy.
    Pereira TA; da Silva GE; Hernández RB; Forti FL; Espósito BP
    Biometals; 2013 Jun; 26(3):439-46. PubMed ID: 23584894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular uptake, cytotoxicity, apoptosis and DNA-binding investigations of Ru(II) complexes.
    Shobha Devi C; Nagababu P; Natarajan S; Deepika N; Venkat Reddy P; Veerababu N; Singh SS; Satyanarayana S
    Eur J Med Chem; 2014 Jan; 72():160-9. PubMed ID: 24418931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metal complexes of curcumin for cellular imaging, targeting, and photoinduced anticancer activity.
    Banerjee S; Chakravarty AR
    Acc Chem Res; 2015 Jul; 48(7):2075-83. PubMed ID: 26158541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of iridium and ruthenium complexes with (N,N), (N,O) and (O,O) coordinating bidentate ligands as potential anti-cancer agents.
    Lucas SJ; Lord RM; Wilson RL; Phillips RM; Sridharan V; McGowan PC
    Dalton Trans; 2012 Dec; 41(45):13800-2. PubMed ID: 23015068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of novel pyrenyl derivatives as anticancer agents.
    Bandyopadhyay D; Sanchez JL; Guerrero AM; Chang FM; Granados JC; Short JD; Banik BK
    Eur J Med Chem; 2015 Jan; 89():851-62. PubMed ID: 25462285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationship study of organometallic bioconjugates of the cyclic octapeptide octreotate.
    Gross A; Habig D; Metzler-Nolte N
    Chembiochem; 2013 Dec; 14(18):2472-9. PubMed ID: 24218362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological activity of neutral and cationic iridium(III) complexes with κP and κP,κS coordinated Ph₂PCH₂S(O)xPh (x = 0-2) ligands.
    Ludwig G; Mijatović S; Ranđelović I; Bulatović M; Miljković D; Maksimović-Ivanić D; Korb M; Lang H; Steinborn D; Kaluđerović GN
    Eur J Med Chem; 2013 Nov; 69():216-22. PubMed ID: 24042044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.